Guarantor and Non-Guarantor Financial Statements (Details) - USD ($)		3 Months Ended								12 Months Ended
		Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2016	Jun. 01, 2016	May 15, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	May 23, 2012
Current assets:
Cash and cash equivalents		$ 55,200,000			$ 72,500,000	$ 72,500,000			$ 177,700,000	$ 72,500,000	$ 177,700,000	$ 169,500,000	$ 55,200,000			$ 72,500,000	$ 177,700,000	$ 169,500,000
Short-term investments													231,000,000			30,000,000
Receivables:
Trade, less allowance for doubtful receivables													137,700,000			116,700,000
Intercompany receivables													0			0
Other													11,900,000			6,100,000
Inventories													201,600,000			219,600,000
Prepaid expenses and other current assets	[1]												18,500,000			56,700,000
Total current assets													655,900,000			501,600,000
Investments in and advances to unconsolidated affiliates													0			0
Property, plant and equipment – net													530,900,000			495,400,000
Long-term intercompany receivables													0			0
Deferred tax assets — net	[1],[2]												159,700,000			162,600,000
Intangible assets – net													26,400,000			30,500,000
Goodwill													37,200,000			37,200,000
Other assets	[1]												33,400,000			19,600,000
Total													1,443,500,000			1,246,900,000
Current liabilities:
Accounts payable													75,800,000			76,700,000
Intercompany payable													0			0
Accrued salaries, wages and related expenses													49,100,000			39,800,000
Other accrued liabilities													39,900,000			52,700,000
Short-term capital leases													200,000			100,000
Total current liabilities													165,000,000			169,300,000
Net liabilities of Salaried VEBA													28,600,000			19,000,000
Deferred tax liabilities													3,300,000			2,100,000
Long-term intercompany payable													0			0
Long-term liabilities													73,200,000			87,500,000
Long-term debt	[1]												368,700,000			194,600,000
Total liabilities													638,800,000			472,500,000
Total stockholders’ equity													804,700,000			774,400,000	1,015,900,000	1,084,200,000
Total													$ 1,443,500,000			1,246,900,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales		331,900,000	$ 320,600,000	$ 334,900,000	343,200,000	316,600,000	$ 336,400,000	$ 367,200,000	371,700,000	1,330,600,000	1,391,900,000	1,356,100,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items		252,400,000	254,700,000	250,400,000	262,000,000	251,000,000	267,300,000	294,800,000	302,300,000	1,019,500,000	1,115,400,000	1,117,500,000
Lower of cost or market inventory write-down		0	0	0	4,900,000	2,600,000	0	0	0	4,900,000	2,600,000	0
Unrealized (gain) loss on derivative instruments		(1,800,000)	(2,000,000)	(10,900,000)	(4,000,000)	(4,300,000)	1,700,000	1,500,000	4,500,000	(18,700,000)	3,400,000	10,400,000
Depreciation and amortization										36,000,000	32,400,000	31,100,000
Selling, general, administrative, research and development										105,000,000	88,100,000	81,400,000
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6										3,400,000	2,400,000	(23,700,000)
(Gain) loss on removal of Union VEBA net assets – Note 6										(100,000)	493,400,000	0
Total selling, administrative, research and development and general										108,300,000	583,900,000	57,700,000
Other operating charges, net										2,800,000	100,000	1,500,000
Total costs and expenses										1,152,800,000	1,737,800,000	1,218,200,000
Operating (loss) income		45,300,000	29,800,000	57,900,000	44,800,000	35,200,000	40,500,000	37,000,000	(458,600,000)	177,800,000	(345,900,000)	137,900,000
Interest expense										(20,300,000)	(24,100,000)	(37,500,000)
Other (expense) income:
Other income, net										(10,300,000)	(1,800,000)	6,700,000
(Loss) income before income taxes										147,200,000	(371,800,000)	107,100,000
Income tax provision										(55,500,000)	135,200,000	(35,300,000)
Earnings in equity of subsidiaries										0	0	0
Net income (loss)		24,500,000	$ 14,900,000	$ 26,000,000	26,300,000	13,300,000	$ 22,100,000	$ 20,200,000	(292,200,000)	91,700,000	(236,600,000)	71,800,000
Comprehensive (loss) income										86,700,000	(172,200,000)	(3,600,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										164,300,000	158,800,000	124,100,000
Cash flows from investing activities:
Capital expenditures										(76,100,000)	(63,100,000)	(59,400,000)
Purchase of available for sale securities										(255,300,000)	(500,000)	(93,500,000)
Proceeds from disposition of available for sale securities										55,000,000	84,000,000	108,200,000
Intercompany loans receivable										0
Net cash (used in) provided by investing activities	[3]									(276,400,000)	20,400,000	(44,700,000)
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes	[4]									(206,000,000)	(30,000,000)	0
Issuance of 5.875% Senior Notes										375,000,000	0	0
Cash paid for debt issuance costs										(6,800,000)	(600,000)
Proceeds from stock option exercises										1,200,000	0	0
Repayment of Convertible Notes	[5]									0	(175,000,000)	0
Proceeds from cash-settled call options related to settlement of Convertible Notes	[5]									0	94,900,000	0
Payment for conversion premium related to settlement of Convertible Notes	[4]									0	(94,900,000)	0
Repayment of capital lease										0	0	(100,000)
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest										0	1,300,000	800,000
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										(2,900,000)	(2,800,000)	(2,400,000)
Repurchase of common stock										(33,300,000)	(49,200,000)	(44,100,000)
Cash dividends paid to stockholders										(32,400,000)	(28,100,000)	(25,400,000)
Cash dividends paid to Parent										0		0
Intercompany loan										0	0	0
Net cash provided by (used in) financing activities	[3]									94,800,000	(284,400,000)	(71,200,000)
Net increase (decrease) in cash and cash equivalents during the period										(17,300,000)	(105,200,000)	8,200,000
Cash and cash equivalents at beginning of period					72,500,000				177,700,000	72,500,000	177,700,000	169,500,000
Cash and cash equivalents at end of period		55,200,000				72,500,000				55,200,000	72,500,000	177,700,000
Ownership interest by parent													100.00%
Parent
Current assets:
Cash and cash equivalents		0			0	0			0	0	0	5,000,000	$ 0			0	0	5,000,000
Short-term investments													0			0
Receivables:
Trade, less allowance for doubtful receivables													0			0
Intercompany receivables													85,800,000			0
Other													0			0
Inventories													0			0
Prepaid expenses and other current assets													100,000			200,000
Total current assets													85,900,000			200,000
Investments in and advances to unconsolidated affiliates													1,012,400,000			1,077,200,000
Property, plant and equipment – net													0			0
Long-term intercompany receivables													80,200,000			0
Deferred tax assets — net													0			0
Intangible assets – net													0			0
Goodwill													0			0
Other assets													0			0
Total													1,178,500,000			1,077,400,000
Current liabilities:
Accounts payable													2,200,000			500,000
Intercompany payable													0			106,500,000
Accrued salaries, wages and related expenses													0			0
Other accrued liabilities													2,900,000			1,400,000
Short-term capital leases													0			0
Total current liabilities													5,100,000			108,400,000
Net liabilities of Salaried VEBA													0			0
Deferred tax liabilities													0			0
Long-term intercompany payable													0			0
Long-term liabilities													0			0
Long-term debt													368,700,000			194,600,000
Total liabilities													373,800,000			303,000,000
Total stockholders’ equity													804,700,000			774,400,000
Total													1,178,500,000			1,077,400,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										0	0	0
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										0	0	0
Lower of cost or market inventory write-down										0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										0	0	0
Selling, general, administrative, research and development										4,200,000	4,300,000	4,100,000
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 6										0	0
Total selling, administrative, research and development and general										4,200,000	4,300,000	4,100,000
Other operating charges, net										0	0	0
Total costs and expenses										4,200,000	4,300,000	4,100,000
Operating (loss) income										(4,200,000)	(4,300,000)	(4,100,000)
Interest expense										(21,600,000)	(23,500,000)	(37,500,000)
Other (expense) income:
Other income, net										(11,100,000)	(2,500,000)	3,700,000
(Loss) income before income taxes										(36,900,000)	(30,300,000)	(37,900,000)
Income tax provision										0	0	0
Earnings in equity of subsidiaries										128,600,000	(206,300,000)	109,700,000
Net income (loss)										91,700,000	(236,600,000)	71,800,000
Comprehensive (loss) income										86,700,000	(172,200,000)	(3,600,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										177,700,000	285,700,000	35,600,000
Cash flows from investing activities:
Capital expenditures										0	0	0
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Intercompany loans receivable										(166,000,000)
Net cash (used in) provided by investing activities										(166,000,000)	0	0
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes										(206,000,000)	(30,000,000)
Issuance of 5.875% Senior Notes										375,000,000
Cash paid for debt issuance costs										(6,800,000)	(600,000)
Proceeds from stock option exercises										1,200,000
Repayment of Convertible Notes											(175,000,000)
Proceeds from cash-settled call options related to settlement of Convertible Notes											94,900,000
Payment for conversion premium related to settlement of Convertible Notes											(94,900,000)
Repayment of capital lease												0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest											0	0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										(2,900,000)	(2,800,000)	(2,400,000)
Repurchase of common stock										(33,300,000)	(49,200,000)	(44,100,000)
Cash dividends paid to stockholders										(32,400,000)	(28,100,000)	(25,400,000)
Cash dividends paid to Parent										0		0
Intercompany loan										(106,500,000)	0	31,300,000
Net cash provided by (used in) financing activities										(11,700,000)	(285,700,000)	(40,600,000)
Net increase (decrease) in cash and cash equivalents during the period										0	0	(5,000,000)
Cash and cash equivalents at beginning of period					0				0	0	0	5,000,000
Cash and cash equivalents at end of period		0				0				0	0	0
Guarantor Subsidiaries
Current assets:
Cash and cash equivalents		52,900,000			72,200,000	72,200,000			175,300,000	72,200,000	175,300,000	157,700,000	52,900,000			72,200,000	175,300,000	157,700,000
Short-term investments													231,000,000			30,000,000
Receivables:
Trade, less allowance for doubtful receivables													133,100,000			114,000,000
Intercompany receivables													100,000			111,200,000
Other													11,400,000			3,800,000
Inventories													197,500,000			216,300,000
Prepaid expenses and other current assets													18,000,000			56,200,000
Total current assets													644,000,000			603,700,000
Investments in and advances to unconsolidated affiliates													40,100,000			31,400,000
Property, plant and equipment – net													499,500,000			464,300,000
Long-term intercompany receivables													0			0
Deferred tax assets — net													154,900,000			155,600,000
Intangible assets – net													26,400,000			30,500,000
Goodwill													37,200,000			37,200,000
Other assets													33,400,000			19,500,000
Total													1,435,500,000			1,342,200,000
Current liabilities:
Accounts payable													68,900,000			73,600,000
Intercompany payable													86,400,000			14,800,000
Accrued salaries, wages and related expenses													47,200,000			38,300,000
Other accrued liabilities													52,400,000			52,300,000
Short-term capital leases													200,000			100,000
Total current liabilities													255,100,000			179,100,000
Net liabilities of Salaried VEBA													28,600,000			19,000,000
Deferred tax liabilities													0			0
Long-term intercompany payable													85,100,000			3,100,000
Long-term liabilities													70,500,000			81,300,000
Long-term debt													0			0
Total liabilities													439,300,000			282,500,000
Total stockholders’ equity													996,200,000			1,059,700,000
Total													1,435,500,000			1,342,200,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										1,301,600,000	1,361,600,000	1,323,400,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										1,000,600,000	1,095,600,000	1,098,300,000
Lower of cost or market inventory write-down										4,900,000	2,600,000
Unrealized (gain) loss on derivative instruments										(18,700,000)	3,400,000	10,400,000
Depreciation and amortization										34,000,000	31,300,000	30,000,000
Selling, general, administrative, research and development										95,000,000	76,500,000	69,700,000
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6										3,400,000	2,400,000	(23,700,000)
(Gain) loss on removal of Union VEBA net assets – Note 6										(100,000)	493,400,000
Total selling, administrative, research and development and general										98,300,000	572,300,000	46,000,000
Other operating charges, net										2,800,000	100,000	1,500,000
Total costs and expenses										1,121,900,000	1,705,300,000	1,186,200,000
Operating (loss) income										179,700,000	(343,700,000)	137,200,000
Interest expense										1,200,000	(900,000)	(600,000)
Other (expense) income:
Other income, net										900,000	3,500,000	3,200,000
(Loss) income before income taxes										181,800,000	(341,100,000)	139,800,000
Income tax provision										(69,000,000)	122,500,000	(50,200,000)
Earnings in equity of subsidiaries										1,700,000	900,000	6,000,000
Net income (loss)										114,500,000	(217,700,000)	95,600,000
Comprehensive (loss) income										109,800,000	(153,500,000)	19,900,000
Cash flows from operating activities:
Net cash (used in) provided by operating activities										177,300,000	(127,200,000)	351,800,000
Cash flows from investing activities:
Capital expenditures										(74,000,000)	(47,900,000)	(56,400,000)
Purchase of available for sale securities										(255,300,000)	(500,000)	(93,500,000)
Proceeds from disposition of available for sale securities										55,000,000	84,000,000	108,200,000
Intercompany loans receivable										110,400,000
Net cash (used in) provided by investing activities										(163,900,000)	35,600,000	(41,700,000)
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes										0	0
Issuance of 5.875% Senior Notes										0
Cash paid for debt issuance costs										0	0
Proceeds from stock option exercises										0
Repayment of Convertible Notes											0
Proceeds from cash-settled call options related to settlement of Convertible Notes											0
Payment for conversion premium related to settlement of Convertible Notes											0
Repayment of capital lease												(100,000)
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest											1,300,000	800,000
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends paid to stockholders										0	0	0
Cash dividends paid to Parent										(200,000,000)		(270,000,000)
Intercompany loan										167,300,000	(12,800,000)	(23,200,000)
Net cash provided by (used in) financing activities										(32,700,000)	(11,500,000)	(292,500,000)
Net increase (decrease) in cash and cash equivalents during the period										(19,300,000)	(103,100,000)	17,600,000
Cash and cash equivalents at beginning of period					72,200,000				175,300,000	72,200,000	175,300,000	157,700,000
Cash and cash equivalents at end of period		52,900,000				72,200,000				52,900,000	72,200,000	175,300,000
Non-Guarantor Subsidiaries
Current assets:
Cash and cash equivalents		2,300,000			300,000	300,000			2,400,000	300,000	2,400,000	6,800,000	2,300,000			300,000	2,400,000	6,800,000
Short-term investments													0			0
Receivables:
Trade, less allowance for doubtful receivables													4,600,000			2,700,000
Intercompany receivables													600,000			1,100,000
Other													500,000			2,300,000
Inventories													8,000,000			6,600,000
Prepaid expenses and other current assets													900,000			1,700,000
Total current assets													16,900,000			14,700,000
Investments in and advances to unconsolidated affiliates													0			0
Property, plant and equipment – net													31,400,000			31,100,000
Long-term intercompany receivables													4,900,000			3,100,000
Deferred tax assets — net													0			0
Intangible assets – net													0			0
Goodwill													0			0
Other assets													0			100,000
Total													53,200,000			49,000,000
Current liabilities:
Accounts payable													4,700,000			2,600,000
Intercompany payable													100,000			4,000,000
Accrued salaries, wages and related expenses													1,900,000			1,500,000
Other accrued liabilities													(700,000)			400,000
Short-term capital leases													0			0
Total current liabilities													6,000,000			8,500,000
Net liabilities of Salaried VEBA													0			0
Deferred tax liabilities													3,300,000			2,100,000
Long-term intercompany payable													0			0
Long-term liabilities													2,700,000			6,200,000
Long-term debt													0			0
Total liabilities													12,000,000			16,800,000
Total stockholders’ equity													41,200,000			32,200,000
Total													53,200,000			49,000,000
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										103,400,000	123,300,000	133,900,000
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										90,000,000	108,400,000	117,800,000
Lower of cost or market inventory write-down										0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										2,000,000	1,100,000	1,100,000
Selling, general, administrative, research and development										8,400,000	9,300,000	9,900,000
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 6										0	0
Total selling, administrative, research and development and general										8,400,000	9,300,000	9,900,000
Other operating charges, net										0	0	0
Total costs and expenses										100,400,000	118,800,000	128,800,000
Operating (loss) income										3,000,000	4,500,000	5,100,000
Interest expense										0	0	0
Other (expense) income:
Other income, net										0	(2,500,000)	400,000
(Loss) income before income taxes										3,000,000	2,000,000	5,500,000
Income tax provision										(600,000)	1,300,000	800,000
Earnings in equity of subsidiaries										0	0	0
Net income (loss)										2,400,000	3,300,000	6,300,000
Comprehensive (loss) income										2,100,000	3,500,000	6,600,000
Cash flows from operating activities:
Net cash (used in) provided by operating activities										9,300,000	300,000	6,700,000
Cash flows from investing activities:
Capital expenditures										(2,100,000)	(15,200,000)	(3,000,000)
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Intercompany loans receivable										(1,300,000)
Net cash (used in) provided by investing activities										(3,400,000)	(15,200,000)	(3,000,000)
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes										0	0
Issuance of 5.875% Senior Notes										0
Cash paid for debt issuance costs										0	0
Proceeds from stock option exercises										0
Repayment of Convertible Notes											0
Proceeds from cash-settled call options related to settlement of Convertible Notes											0
Payment for conversion premium related to settlement of Convertible Notes											0
Repayment of capital lease												0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest											0	0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends paid to stockholders										0	0	0
Cash dividends paid to Parent										0		0
Intercompany loan										(3,900,000)	12,800,000	(8,100,000)
Net cash provided by (used in) financing activities										(3,900,000)	12,800,000	(8,100,000)
Net increase (decrease) in cash and cash equivalents during the period										2,000,000	(2,100,000)	(4,400,000)
Cash and cash equivalents at beginning of period					300,000				2,400,000	300,000	2,400,000	6,800,000
Cash and cash equivalents at end of period		2,300,000				300,000				2,300,000	300,000	2,400,000
Senior Notes | Senior Notes Due 2024 [Member]
Cash flows from financing activities:
Principal amount of notes															$ 375,000,000
Debt Instrument, Interest Rate, Stated Percentage															5.875%
Senior Notes | Senior Notes Due 2020
Current liabilities:
Long-term debt														$ 197,800,000
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes											(30,000,000)
Principal amount of notes																			$ 225,000,000
Debt Instrument, Interest Rate, Stated Percentage																			8.25%
Consolidating Adjustments
Current assets:
Cash and cash equivalents		0			0	0			0	0	0	0	0			0	$ 0	$ 0
Short-term investments													0			0
Receivables:
Trade, less allowance for doubtful receivables													0			0
Intercompany receivables													(86,500,000)			(112,300,000)
Other													0			0
Inventories													(3,900,000)			(3,300,000)
Prepaid expenses and other current assets													(500,000)			(1,400,000)
Total current assets													(90,900,000)			(117,000,000)
Investments in and advances to unconsolidated affiliates													(1,052,500,000)			(1,108,600,000)
Property, plant and equipment – net													0			0
Long-term intercompany receivables													(85,100,000)			(3,100,000)
Deferred tax assets — net													4,800,000			7,000,000
Intangible assets – net													0			0
Goodwill													0			0
Other assets													0			0
Total													(1,223,700,000)			(1,221,700,000)
Current liabilities:
Accounts payable													0			0
Intercompany payable													(86,500,000)			(125,300,000)
Accrued salaries, wages and related expenses													0			0
Other accrued liabilities													(14,700,000)			(1,400,000)
Short-term capital leases													0			0
Total current liabilities													(101,200,000)			(126,700,000)
Net liabilities of Salaried VEBA													0			0
Deferred tax liabilities													0			0
Long-term intercompany payable													(85,100,000)			(3,100,000)
Long-term liabilities													0			0
Long-term debt													0			0
Total liabilities													(186,300,000)			(129,800,000)
Total stockholders’ equity													(1,037,400,000)			(1,091,900,000)
Total													$ (1,223,700,000)			$ (1,221,700,000)
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
Net sales										(74,400,000)	(93,000,000)	(101,200,000)
Cost of products sold:
Cost of products sold, excluding depreciation and amortization and other items										(71,100,000)	(88,600,000)	(98,600,000)
Lower of cost or market inventory write-down										0	0
Unrealized (gain) loss on derivative instruments										0	0	0
Depreciation and amortization										0	0	0
Selling, general, administrative, research and development										(2,600,000)	(2,000,000)	(2,300,000)
Net periodic postretirement benefit cost (income) relating to VEBAs – Note 6										0	0	0
(Gain) loss on removal of Union VEBA net assets – Note 6										0	0
Total selling, administrative, research and development and general										(2,600,000)	(2,000,000)	(2,300,000)
Other operating charges, net										0	0	0
Total costs and expenses										(73,700,000)	(90,600,000)	(100,900,000)
Operating (loss) income										(700,000)	(2,400,000)	(300,000)
Interest expense										100,000	300,000	600,000
Other (expense) income:
Other income, net										(100,000)	(300,000)	(600,000)
(Loss) income before income taxes										(700,000)	(2,400,000)	(300,000)
Income tax provision										14,100,000	11,400,000	14,100,000
Earnings in equity of subsidiaries										(130,300,000)	205,400,000	(115,700,000)
Net income (loss)										(116,900,000)	214,400,000	(101,900,000)
Comprehensive (loss) income										(111,900,000)	150,000,000	(26,500,000)
Cash flows from operating activities:
Net cash (used in) provided by operating activities										(200,000,000)	0	(270,000,000)
Cash flows from investing activities:
Capital expenditures										0	0	0
Purchase of available for sale securities										0	0	0
Proceeds from disposition of available for sale securities										0	0	0
Intercompany loans receivable										56,900,000
Net cash (used in) provided by investing activities										56,900,000	0	0
Cash flows from financing activities:
Repayment of principal and redemption premium of 8.25% Senior Notes										0	0
Issuance of 5.875% Senior Notes										0
Cash paid for debt issuance costs										0	0
Proceeds from stock option exercises										0
Repayment of Convertible Notes											0
Proceeds from cash-settled call options related to settlement of Convertible Notes											0
Payment for conversion premium related to settlement of Convertible Notes											0
Repayment of capital lease												0
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest											0	0
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares										0	0	0
Repurchase of common stock										0	0	0
Cash dividends paid to stockholders										0	0	0
Cash dividends paid to Parent										200,000,000		270,000,000
Intercompany loan										(56,900,000)	0	0
Net cash provided by (used in) financing activities										143,100,000	0	270,000,000
Net increase (decrease) in cash and cash equivalents during the period										0	0	0
Cash and cash equivalents at beginning of period					$ 0				$ 0	0	0	0
Cash and cash equivalents at end of period		$ 0				$ 0				$ 0	$ 0	$ 0

[1] See Note 1 for discussion of our adoption of ASU 2015-03 and ASU 2015-17 (as defined in Note 1).

[2] See Note 5 and Note 8 for discussion of our adoption of ASU 2016-09 (as defined in Note 1).

[3] See Note 13 for supplemental disclosure on non-cash transactions.

[4] See Note 3 for more information relating to the 8.25% Senior Notes (defined in Note 3) and the Convertible Notes.

[5] See Note 2 for the impact of reclassifying repair parts to other current and other long-term assets.